Abraham Mittelman serves as Executive at AV Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Abraham Mittelman has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 20, 2015 involved transacting 1,200,000 shares valued at $0.
Abraham Mittelman currently holds 17,509,079 shares of AV Therapeutics, Inc. (AVTH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Abraham Mittelman has been a net neutral trader of AVTH stock. They have purchased $0 and sold $0 worth of shares.
Abraham Mittelman's most recent insider trade was on Jan 20, 2015, when they sold 1,200,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |